A real-world analysis of the safety and efficacy of BCMA-directed CAR T-cell therapy for patients with relapsed/refractory multiple myeloma and baseline renal impairment Meeting Abstract
| Authors: | Habib, A.; Ahmed, N.; Khan, A. M.; Chang, D.; Paul, B.; Shaikh, H.; Strouse, C.; Struble, E.; Uegel, A.; Davis, J. A.; Green, K. M.; Hashmi, H.; Mahmoudjafari, Z.; Mushtaq, M. U.; McGuirk, J. P.; Abdallah, A.; Atrash, S.; Friend, R. |
| Abstract Title: | A real-world analysis of the safety and efficacy of BCMA-directed CAR T-cell therapy for patients with relapsed/refractory multiple myeloma and baseline renal impairment |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 2009 |
| Language: | English |
| ACCESSION: | WOS:001412856700033 |
| DOI: | 10.1182/blood-2024-208799 |
| PROVIDER: | wos |
| Notes: | Source: Wos |
